XML 11 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 43,068 $ 25,802
Short-term investments 12,419 33,481
Accounts receivable, net 81,047 78,881
Inventory, net 70,025 53,160
Prepaid expenses and other current assets 22,841 17,690
Total current assets 229,400 209,014
Property and equipment, net 12,960 14,863
Right-of-use lease assets 708 2,787
Other assets 5,882 6,483
Total assets 248,950 233,147
Current liabilities:    
Accounts payable 12,017 11,709
Accrued clinical and manufacturing liabilities 19,663 25,402
Accrued payroll and employee liabilities 8,748 9,554
Other accrued liabilities 48,500 41,755
Current lease liabilities 780 3,037
Total current liabilities 89,708 91,457
Non-current notes payable, net 107,487 25,026
Non-current convertible notes payable, net 32,176 149,700
Other non-current liabilities 4,694 615
Total liabilities 234,065 266,798
Stockholders' equity (deficit):    
Common stock 1,833 1,521
Series A convertible preferred stock 7,862 0
Additional paid-in capital 1,942,025 1,884,409
Accumulated other comprehensive loss (0) 13
Accumulated deficit (1,936,835) (1,919,594)
Total stockholders' equity (deficit) 14,885 (33,651)
Total liabilities and stockholders' equity (deficit) $ 248,950 $ 233,147